Unsupervised and externally validated clinical cluster analysis from the U-BIOPRED paediatric cohorts
S. Hashimoto (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), D. Lefaudeux (Lyon, France), A. T. Bansal (Cambridge, United Kingdom), B. De Meulder (Lyon, France), C. Murray (Manchester, United Kingdom), A. Bush (London, United Kingdom), U. Frey (Basel, Switzerland), F. Singer (Zurich/Bern, Switzerland), G. Hedlin (Stockholm, Sweden), B. Nordlund (Stockholm, Sweden), H. Bisgaard (Copenhagen, Denmark), W. Van Aalderen (Amsterdam, Netherlands), S. J.H Vijverberg (Amsterdam, Netherlands), N. H. Vissing (Copenhagen, Denmark), Z. Zolkipli (Southampton, United Kingdom), A. Selby (Southampton, United Kingdom), S. J. Fowler (Manchester, United Kingdom), D. Shaw (Nottingham, United Kingdom), A. R. Sousa (Stockley Park, United Kingdom), S. Wagers (Maasmechelen, Belgium), J. Corfield (Nottingham, United Kingdom), I. Pandis (High Wycombe, United Kingdom), A. Rowe (High Wycombe, United Kingdom), M. Puig Valls (Barcelona, Spain), G. Praticò (Verona, Italy), C. Auffray (Lyon, France), K. Fan Chung (London, United Kingdom), E. H. Bel (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), A. Maitland Van Der Zee (Amsterdam, Netherlands), P. J. Sterk (Amsterdam, Netherlands), L. Fleming (London, United Kingdom), G. Roberts (Southampton, United Kingdom)
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Session: Paediatric asthma: new mechanisms and tools
Session type: Thematic Poster
Number: 1301
Disease area: Airway diseases, Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hashimoto (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), D. Lefaudeux (Lyon, France), A. T. Bansal (Cambridge, United Kingdom), B. De Meulder (Lyon, France), C. Murray (Manchester, United Kingdom), A. Bush (London, United Kingdom), U. Frey (Basel, Switzerland), F. Singer (Zurich/Bern, Switzerland), G. Hedlin (Stockholm, Sweden), B. Nordlund (Stockholm, Sweden), H. Bisgaard (Copenhagen, Denmark), W. Van Aalderen (Amsterdam, Netherlands), S. J.H Vijverberg (Amsterdam, Netherlands), N. H. Vissing (Copenhagen, Denmark), Z. Zolkipli (Southampton, United Kingdom), A. Selby (Southampton, United Kingdom), S. J. Fowler (Manchester, United Kingdom), D. Shaw (Nottingham, United Kingdom), A. R. Sousa (Stockley Park, United Kingdom), S. Wagers (Maasmechelen, Belgium), J. Corfield (Nottingham, United Kingdom), I. Pandis (High Wycombe, United Kingdom), A. Rowe (High Wycombe, United Kingdom), M. Puig Valls (Barcelona, Spain), G. Praticò (Verona, Italy), C. Auffray (Lyon, France), K. Fan Chung (London, United Kingdom), E. H. Bel (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), A. Maitland Van Der Zee (Amsterdam, Netherlands), P. J. Sterk (Amsterdam, Netherlands), L. Fleming (London, United Kingdom), G. Roberts (Southampton, United Kingdom). Unsupervised and externally validated clinical cluster analysis from the U-BIOPRED paediatric cohorts. 1301
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: